중앙백신
072020KOSDAQ기초 의약물질 제조업64.3 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
Central Vaccine is a company specializing in the development and production of animal vaccines and biological products, focusing on disease prevention and control in the livestock industry. Recent outbreaks of African Swine Fever and Highly Pathogenic Avian Influenza have increased demand for vaccines, necessitating the development of new products to counteract the diminishing efficacy of existing ones. The company is expanding into new markets, including China and Brazil, to broaden its global presence.
Number of Employees
194people
Average Salary
57.1M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Lower than industry avg (good)
Well below industry avg
In line with industry avg
Avg ▲8.3% (2-year basis)
Avg ▼2.6% (2-year basis)
Avg ROE 6.3% (declining, 3yr)
Detailed News Sentiment
- Positive감사원도 설득한 'K-방역 승부수'…ASF 백신 세계무대 띄운 검역본부
중앙백신 관련 ASFVax 개발 가속화로 글로벌 시장 선점 기회 확대.
- Positive중앙백신, 58억 규모 구제역 SAT1 예방백신 조달 공급계약
중앙백신이 구제역 SAT1 예방백신 공급계약으로 대규모 매출 증대 기대.
- Positive중앙백신, 조달청과 58억 규모 구제역 백신 공급계약
중앙백신이 조달청과 구제역 백신 공급 계약 체결로 인해 긍정적인 재무적 성과와 시장 신뢰를 얻었다.
Detailed Momentum
52w lower range (34%)
1m 0.54% (flat)
Volume decreasing
Detailed Disclosure
- Positive단일판매ㆍ공급계약체결2026-07-08
- Neutral주식소각결정2026-06-25
